Vous êtes sur la page 1sur 1

61980 Federal Register / Vol. 71, No.

203 / Friday, October 20, 2006 / Notices

This notice announces a forthcoming Persons attending FDA’s advisory DEPARTMENT OF HEALTH AND
meeting of a public advisory committee committee meetings are advised that the HUMAN SERVICES
of the Food and Drug Administration agency is not responsible for providing
(FDA). The meeting will be open to the access to electrical outlets. Food and Drug Administration
public. FDA welcomes the attendance of the
Name of Committee: Arthritis Circulatory System Devices Panel of
public at its advisory committee the Medical Devices Advisory
Advisory Committee. meetings and will make every effort to
General Function of the Committee: Committee; Notice of Meeting
accommodate persons with physical
To provide advice and AGENCY: Food and Drug Administration,
disabilities or special needs. If you
recommendations to the agency on HHS.
require special accommodations due to
FDA’s regulatory issues. ACTION: Notice.
a disability, please contact Johanna
Date and Time: The meeting will be
Clifford at least 7 days in advance of the
held on November 29, 2006, from 8 a.m. This notice announces a forthcoming
to 5 p.m. meeting.
meeting of a public advisory committee
Location: Hilton Washington DC Notice of this meeting is given under of the Food and Drug Administration
North/Gaithersburg, The Ballrooms, 620 the Federal Advisory Committee Act (5 (FDA). The meeting will be open to the
Perry Pkwy., Gaithersburg, MD. U.S.C. app. 2). public.
Contact Person: Johanna M. Clifford, Dated: October 13, 2006. Name of Committee: Circulatory
Center for Drug Evaluation and Research Randall W. Lutter, System Devices Panel of the Medical
(HFD–21), Food and Drug Devices Advisory Committee.
Administration, 5600 Fishers Lane (for Associate Commissioner for Policy.
General Function of the Committee:
express delivery, 5630 Fishers Lane, rm. [FR Doc. 06–8787 Filed 10–19–06; 8:45 am] To provide advice and
1093), Rockville, MD 20857, 301–827– BILLING CODE 4160–01–S recommendations to the agency on
7001, FAX: 301–827–6776, e-mail: FDA’s regulatory issues.
Johanna.Clifford@fda.hhs.gov, or FDA Date and Time: The meeting will be
Advisory Committee Information Line, DEPARTMENT OF HEALTH AND held on December 7 and 8, 2006, from
1–800–741–8138 (301–443–0572 in the HUMAN SERVICES 8 a.m. to 5:30 p.m.
Washington, DC area), code Location: Hilton Washington DC
3014512532. Please call the Information Food and Drug Administration North/Gaithersburg, Salons A, B, and C,
Line for up-to-date information on this 620 Perry Pkwy., Gaithersburg, MD.
meeting. The background material will Neurological Devices Panel of the Contact Person: James Swink, Center
become available no later than the day Medical Devices Advisory Committee; for Devices and Radiological Health
before the meeting and will be posted Notice of Postponement of Meeting (CDRH) (HFZ–450), Food and Drug
on FDA’s Web site at http:// Administration, 9200 Corporate Blvd.,
www.fda.gov/ohrms/dockets/ac/ AGENCY: Food and Drug Administration,
Rockville, MD 20850, 301–443–8262,
acmenu.htm under the heading HHS. ext. 163, or FDA Advisory Committee
‘‘Arthritis Advisory Committee.’’ (Click ACTION: Notice. Information Line, 1–800–741–8138
on the year 2006 and scroll down to the (301–443–0572 in the Washington, DC
above named committee meeting). The Food and Drug Administration area), code 3014512625. Please call the
Agenda: The committee will discuss (FDA) is postponing the meeting of the Information Line for up-to-date
the safety and efficacy of the Neurological Devices Panel scheduled information on this meeting.
nonsteriodal anti-inflammatory drug for October 31, 2006. The meeting was Agenda: The committee will discuss
(COX–2 inhibitor) new drug application announced in the Federal Register of and make recommendations regarding
(NDA) 20–998/S021, CELEBREX September 22, 2006 (71 FR 55491). issues related to stent thrombosis in
(celecoxib), Pfizer, Inc., for the proposed FDA’s Center for Devices and coronary drug-eluting stents.
indication of the relief of the signs and Radiological Health will further Background information for the topic,
symptoms of juvenile rheumatoid including the agenda and questions for
evaluate data relevant to the topic. A
arthritis in patients 2 years and older. the committee, will be available to the
future meeting date will be announced
Procedure: Interested persons may public 1 business day before the
in the Federal Register.
present data, information, or views, meeting on the Internet at http://
orally or in writing, on issues pending Contact Person: Janet L. Scudiero, www.fda.gov/cdrh/panel (click on
before the committee. Written Center for Devices and Radiological Upcoming CDRH Advisory Panel/
submissions may be made to the contact Health (HFZ–410), Food and Drug Committee Meetings).
person on or before November 15, 2006. Administration, 9200 Corporate Blvd., Procedure: Interested persons may
Oral presentations from the public will Rockville, MD 20850, 301–594–1184, or present data, information, or views,
be scheduled between approximately FDA Advisory Committee Information orally or in writing, on issues pending
11:30 a.m. and 12:30 p.m. Time allotted Line, 1–800–741–8138 (301–443–0572 before the committee. Written
for each presentation may be limited. in the Washington, DC area), code submissions may be made to the contact
Those desiring to make formal oral 3014512513. Please call the Information person on or before November 15, 2006.
presentations should notify the contact Line for up-to-date information on this Oral presentations from the public will
person and submit a brief statement of meeting. be scheduled on both days for
the general nature of the evidence or Dated: October 13, 2006.
approximately 1 hour at the beginning
arguments they wish to present, the of committee deliberations and for
jlentini on PROD1PC65 with NOTICES

names and addresses of proposed Randall W. Lutter, approximately 1 hour near the end of
participants, and an indication of the Associate Commissioner for Policy and the deliberations. Time allotted for each
approximate time requested to make Planning. presentation may be limited. Those
their presentation on or before [FR Doc. 06–8788 Filed 10–19–06; 8:45 am] desiring to make formal oral
November 15, 2006. BILLING CODE 4160–01–S presentations should notify the contact

VerDate Aug<31>2005 15:52 Oct 19, 2006 Jkt 211001 PO 00000 Frm 00035 Fmt 4703 Sfmt 4703 E:\FR\FM\20OCN1.SGM 20OCN1